An interventional study of F-PGT in Prolonged Grief Disorder (PGD), sponsored by University of Pittsburgh. Enrolling by invitation at 2 sites in United States. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2026-07-15.
Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Prolonged Grief Disorder with a site in United States — 4 open to participants now, 5 under way, none of them phase 3. Prolonged Grief Disorder · United States.
Among the 15 studies in Prolonged Grief Disorder with a site in United States, this one is the 10th largest by planned enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2025, is one of 10 with no phase, and was the 13th registered.
40 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.
Browse Prolonged Grief Disorder studies →4 of the 15 studies in Prolonged Grief Disorder with a site in United States are open now. Recruiting first, the newest first:
University of Virginia · Sites in United States
Ages 18–65 · Healthy volunteers
RAND · Sites in United States
Ages 18+
Medical College of Wisconsin · Sites in United States
Ages 40–89
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 9 Prolonged Grief Disorder studies recruiting now, 7 set no upper age limit and 2 stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 8 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 73 across 36 interventional studies indexed under Prolonged Grief Disorder.
Median enrollment 42 across the 14 interventional studies, 0 across the 1 observational. Of the 7 that completed or were terminated, 3 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 10 most frequent:
University of Pittsburgh is the lead sponsor of 1,422 studies on the registry; 170 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.
University of Pittsburgh has 1 study filed under Prolonged Grief Disorder — fewer than ten, so there is no comparison to draw.
3 of the studies in Prolonged Grief Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05026827Medical College of WisconsinIyengar Yoga for Prolonged Grief Disorder | 2026-12 |
| NCT07318090University of PittsburghF-PGT - Prolonged Grief Treatment for Families Affected by Suicide | 2026-12-31 |
| NCT06724289University of VirginiaPsilocybin for Prolonged Grief Disorder | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Prolonged Grief Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot open trial is being done to better understand the needs of families who have lost a parent to suicide at least a year ago and who have children ages 8-14 and to develop and test Family-Prolonged Grief Treatment (F-PGT), a modification of prolonged grief therapy (PGT) as a way to help these families. PGT has been proven efficacious for adults with prolonged grief. The therapy has been adapted to include work with parents in helping their children (aged 8-14) and to include sessions with the child. All assessment and treatment sessions of the study are being conducted virtually.
Interested potential adult participants will first complete a preliminary screening conducted by phone or secure zoom. Eligible and interested families will meet with a study clinician to provide written informed consent and child assent to participate in a 2-step study process. Step 1 is baseline assessment and confirming study eligibility, and step 2 is Prolonged Grief Treatment for Families (F-PGT).
Families who give consent will complete assessments to confirm eligibility for the study. Those who are not eligible will conclude their study participation. Eligible families will complete the remaining baseline assessments and proceed to step 2, treatment.
F-PGT includes 16 virtual sessions where a therapist will meet with either the parent or child, or both. All sessions will be recorded to continue optimize the therapy.
In addition, participants will complete regular assessments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Youth exclusion criteria:
Parent/Caregiver Exclusion criteria:
Eligible families will receive 16 online sessions of Family-Prolonged Grief Treatment (F-PGT).
Behavioral: F-PGT
Family- Prolonged Grief Treatment (F-PGT) is a specialized talk therapy to help families who have lost a parent to suicide. It is based on Prolonged Grief Therapy (PGT) that is efficacious for adults and is now adapted for parents and their children ages 8 to 14. The therapy includes 16 online sessions where a therapist meets with the parent alone, the child alone, or both together. Activities for children are designed to match their age and understanding. The therapy guides families through six steps: understanding and accepting grief, seeing promise in the future, strengthening relationships, sharing the story of the death, living with reminders, and connecting with memories. As a part of the focus on strengthening relationships parents are encouraged to invite a friend or relative to join a session.
Total Score on Feasibility of Intervention Measure (FIM) at End of Treatment
Total scores from the Feasibility of Intervention Measure (FIM) will be used to assess participants' perception of intervention feasibility. Total Score FIM: 4-8 Low feasibility; 9-15 Moderate feasibility; 16-20 High feasibility.
Time frame: End of treatment at 20 weeks
Total Score on Acceptability of Intervention Measure (AIM) at End of Treatment
Total scores from the Acceptability of Intervention Measure (AIM) will be used to assess participants' perception of intervention acceptability. Total Score AIM: 4-8 Low acceptability; 9-15 Moderate acceptability; 16-20 High acceptability.
Time frame: End of treatment at 20 weeks
Change in Inventory of Complicated Grief (ICG) Total Score
Total scores from the Inventory of Complicated Grief (ICG) will be used to assess severity of complicated grief symptoms in adults. Total Score ICG: 0-24 Minimal grief; 25-29 Mild/moderate grief; ≥30 Clinically significant grief.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Inventory for Complicated Grief-Revised for Children (ICG-RC) Total Score
Total scores from the Inventory for Complicated Grief-Revised for Children (ICG-RC) will be used to assess severity of prolonged grief symptoms in children and adolescents. Total Score ICG-RC: 28-67 Minimal/mild grief; ≥68 Clinically significant prolonged grief.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Clinical Global Impression (CGI-S and CGI-I) Scores
Clinician-rated scores from the Clinical Global Impression scale will be used to assess global severity and improvement. CGI-Severity: 1-2 Normal/mild; 3-4 Moderate; 5-7 Severe. CGI-Improvement: 1-2 Improved; 3-4 No change; 5-7 Worsened.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Child Global Assessment Scale (C-GAS) Total Score
Total scores from the Children's Global Assessment Scale (C-GAS) will be used to assess overall child functioning. Total Score C-GAS: 91-100 Superior functioning; 71-90 Good functioning; 51-70 Moderate impairment; 31-50 Serious impairment; 1-30 Severe impairment.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Global Assessment Scale (GAS) Total Score (Parent)
Total scores from the Global Assessment Scale (GAS) will be used to assess overall parental functioning. Higher scores indicate better functioning.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Work and Social Adjustment Scale (WSAS) Total Score
Total scores from the Work and Social Adjustment Scale (WSAS) will be used to assess functional impairment. Total Score WSAS: 0-9 Low impairment; 10-20 Significant impairment; \>20 Moderately severe to severe impairment.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Parental Reflective Functioning Questionnaire (PRFQ) Total Score
Total scores from the Parental Reflective Functioning Questionnaire (PRFQ) will be used to assess parents' capacity to reflect on their child's mental states. Higher scores indicate greater reflective functioning, except for the Pre-mentalizing subscale where higher scores indicate less adaptive functioning.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Coping with Children's Negative Emotions Scale (CCNES) Total Score
Total scores from the Coping with Children's Negative Emotions Scale (CCNES) will be used to assess parental responses to children's negative emotions. Higher supportive response scores reflect more adaptive parenting.
Time frame: Baseline; 20 weeks assessment
Change in Child and Adolescent Reflective Functioning Scale (CARFS) Score
Total scores from the Child and Adolescent Reflective Functioning Scale (CARFS) will be used to assess children's ability to understand their own and others' mental states. Higher scores indicate greater reflective functioning.
Time frame: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Child-Parent Relationship Scale (CPRS) Total Score
Total scores from the Child-Parent Relationship Scale (CPRS) will be used to assess parent-child relationship quality. Higher scores indicate more positive relationship quality or greater stress on stress-related subscales.
Time frame: Baseline; 4 weeks; 12 weeks; 20 weeks assessment
Presence of Psychiatric Diagnoses as Assessed by Structured Clinical Interview for DSM-5 (SCID-5)
Diagnostic outcomes from the Structured Clinical Interview for DSM-5 (SCID-5) will be used to assess the presence of DSM-5 psychiatric disorders in adults for inclusion/exclusion criteria and will help in assessing global functioning. Each disorder will be coded as 0 (not present), 1 (subthreshold), or 2 (present).
Time frame: Baseline
Change in Psychiatric Diagnoses as Assessed by Structured Clinical Interview for DSM-5 (SCID-5)
Diagnostic outcomes from the Structured Clinical Interview for DSM-5 (SCID-5) will be used to assess changes in DSM-5 psychiatric disorders in adults and in global functioning. Each disorder will be coded as 0 (not present), 1 (subthreshold), or 2 (present).
Time frame: End of treatment at 20 weeks
Presence of Psychiatric Diagnoses as Assessed by K-SADS-PL (Child and Parent Versions)
Diagnostic outcomes from the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL) will be used to assess DSM psychiatric disorders in children and adolescents for inclusion/exclusion criteria and will help in assessing global functioning. Each disorder will be coded as 1 (not present), 2 (subthreshold), or 3 (present).
Time frame: Baseline; 20 weeks assessment
Change in DSM Psychiatric Diagnoses as Assessed by Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL)
Diagnostic outcomes from the Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL) will be used to assess changes in DSM psychiatric disorders in children and adolescents and in global functioning. Each disorder will be coded as 1 (not present), 2 (subthreshold), or 3 (present).
Time frame: End of treatment at 20 weeks
Total Score on Prolonged Grief Disorder-13 (PG-13) Scale
Total scores from the Prolonged Grief Disorder-13 (PG-13) scale will be used to assess severity of prolonged grief symptoms. Total Score PG-13: 10-29 Mild grief; 30-50 Clinically significant prolonged grief.
Time frame: Baseline
Change in Total Score on Prolonged Grief Disorder-13 (PG-13) Scale
Total scores from the Prolonged Grief Disorder-13 (PG-13) scale will be used to assess severity of prolonged grief symptoms. Total Score PG-13: 10-29 Mild grief; 30-50 Clinically significant prolonged grief.
Time frame: 20 weeks assessment
Observed Parent-Child Communication Behaviors During Virtual Interaction Tasks
Observed parent-child communication behaviors will be assessed during three 5-minute structured virtual interaction tasks (discussion of friendships, resolution of a minor conflict, and planning a "dream vacation"). Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Higher scores indicate more adaptive communication behaviors.
Time frame: Baseline
Change in Observed Parent-Child Communication Behaviors During Virtual Interaction Tasks
Change in observed parent-child communication behaviors will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Positive change scores indicate improvement in communication behaviors from baseline.
Time frame: End of treatment at 20 weeks
Observed Parent-Child Attachment Behaviors During Virtual Interaction Tasks
Observed attachment-related behaviors between parent and child will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Higher scores indicate more secure attachment behaviors.
Time frame: Baseline
Change in Observed Parent-Child Attachment Behaviors During Virtual Interaction Tasks
Change in observed parent-child attachment behaviors will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained raters using a standardized observational coding system. Positive change scores indicate improvement in attachment behaviors from baseline.
Time frame: End of treatment at 20 weeks
Observed Parent and Child Reflective Functioning During Virtual Interaction Tasks
Observed reflective functioning of parents and children will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained staff using a validated reflective functioning coding framework. Higher scores indicate greater capacity to recognize and interpret mental states.
Time frame: Baseline
Change in Observed Parent and Child Reflective Functioning During Virtual Interaction Tasks
Change in observed reflective functioning of parents and children will be assessed during three 5-minute structured virtual interaction tasks. Video-recorded sessions will be coded by trained staff using a validated reflective functioning coding framework. Positive change scores indicate improvement in reflective functioning from baseline.
Time frame: End of treatment at 20 weeks
Change in Depressive Symptoms as Assessed by Quick Inventory of Depressive Symptomatology (QIDS)
Total scores from the Quick Inventory of Depressive Symptomatology (QIDS) will be used to assess depressive symptom severity. Higher scores indicate greater depression severity.
Time frame: Baseline; 12 weeks; 20 weeks assessment
Change in Anxiety Symptoms as Assessed by Generalized Anxiety Disorder-7 (GAD-7)
Total scores from the Generalized Anxiety Disorder-7 (GAD-7) will be used to assess anxiety severity. Higher scores indicate greater anxiety.
Time frame: Baseline; 12 weeks; 20 weeks assessment
Change in Posttraumatic Stress Symptoms as Assessed by Davidson Trauma Scale (DTS)
Total scores from the Davidson Trauma Scale (DTS) will be used to assess severity of posttraumatic stress symptoms. Higher scores indicate greater trauma-related distress.
Time frame: Baseline; 12 weeks; 20 weeks assessment
Change in Child Anxiety and Depression Symptoms as Assessed by RCADS-25 (Child and Parent Versions)
Total scores from the Revised Children's Anxiety and Depression Scale - Short Version (RCADS-25) will be used to assess anxiety and depressive symptoms in children and adolescents. Higher scores indicate greater symptom severity.
Time frame: Baseline; 12 weeks; 20 weeks assessment
Suicidal Ideation and Behavior as Assessed by Columbia-Suicide Severity Rating Scale (C-SSRS)
Scores from the Columbia-Suicide Severity Rating Scale (C-SSRS) will be used to assess severity and frequency of suicidal ideation and behavior in adults and children. The C-SSRS ideation severity subscale is scored on a 5-point ordinal scale ranging from 1 (wish to be dead) to 5 (active suicidal ideation with specific plan and intent), with higher scores indicating greater severity of suicidal ideation and a worse clinical outcome.
Time frame: Baseline; weekly during treatment; 20 weeks assessment
Change in Family Functioning as Assessed by Family Adaptability and Cohesion Scale (FACES-IV-SF)
Total scores from the Family Adaptability and Cohesion Scale - Short Form (FACES-IV-SF) will be used to assess family functioning. Higher scores indicate healthier family dynamics.
Time frame: Baseline; 12 weeks; 20 weeks assessment
Change in Parenting Competence as Assessed by Parenting Sense of Competency Scale (PSCS)
Total scores from the Parenting Sense of Competency Scale (PSCS) will be used to assess parental efficacy and satisfaction. Higher scores indicate greater perceived parenting competence.
Time frame: Baseline; 12 weeks; 20 weeks assessment
Plan to share: No — Not required by the funding agency.
Started Dec 2025 (actual). Primary completion is estimated for Dec 2026, 12 months after the start.
Of 27 interventional studies with no phase under Prolonged Grief Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 57. This study's planned 12 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.